Also have to take total revenues in the context of this statement re respitory products...
"Revenues from the Company’s respiratory product line (Breath-A-Tech and Funhaler) were down slightly
reflecting historical seasonal trends and the Company’s decision to cease sales and marketing efforts for the respiratory line outside of Australia."
So there growth will come from recell as they are now only marketing in Austrlia for other products
- Forums
- ASX - By Stock
- avita medical reports strong half year financi
Also have to take total revenues in the context of this...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
|
|||||
Last
$2.53 |
Change
0.150(6.30%) |
Mkt cap ! $172.2M |
Open | High | Low | Value | Volume |
$2.44 | $2.54 | $2.43 | $877.0K | 352.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 250 | $2.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.54 | 6577 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 250 | 2.520 |
1 | 20161 | 2.510 |
1 | 594 | 2.500 |
1 | 657 | 2.470 |
1 | 75 | 2.450 |
Price($) | Vol. | No. |
---|---|---|
2.540 | 6577 | 1 |
2.550 | 6935 | 4 |
2.560 | 350 | 1 |
2.570 | 1000 | 1 |
2.590 | 3921 | 1 |
Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |